Engage with assets across the pipeline to identify patient-relevant concepts, guide asset team's decision on COA instruments that support clinical trials endpoints. Determine if COA instruments are fit for purpose for label inclusion; guide the cross Director, Clinical, Development, Assessment, Strategy, Senior, Technology